Cargando…
Correction to ‘Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity’
Autores principales: | Gayle, Sophia, Aiello, Robert, Leelatian, Nalin, Beckta, Jason M, Bechtold, Jane, Bourassa, Patricia, Csengery, Johanna, Maguire, Robert J, Marshall, Dan, Sundaram, Ranjini K, Van Doorn, Jinny, Jones, Kelli, Moore, Hunter, Lopresti-Morrow, Lori, Paradis, Timothy, Tylaska, Laurie, Zhang, Qing, Visca, Hannah, Reshetnyak, Yana K, Andreev, Oleg A, Engelman, Donald M, Glazer, Peter M, Bindra, Ranjit S, Paralkar, Vishwas M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651162/ https://www.ncbi.nlm.nih.gov/pubmed/34888524 http://dx.doi.org/10.1093/narcan/zcab047 |
Ejemplares similares
-
Tumor-selective, antigen-independent delivery of a pH sensitive peptide-topoisomerase inhibitor conjugate suppresses tumor growth without systemic toxicity
por: Gayle, Sophia, et al.
Publicado: (2021) -
Tumor treatment by pHLIP-targeted antigen delivery
por: DuPont, Michael, et al.
Publicado: (2023) -
Eradication of tumors and development of anti-cancer immunity using STINGa targeted by pHLIP
por: Moshnikova, Anna, et al.
Publicado: (2022) -
Targeting IDH1/2 mutant cancers with combinations of ATR and PARP inhibitors
por: Sule, Amrita, et al.
Publicado: (2021) -
Persistent STAG2 mutation despite multimodal therapy in recurrent pediatric glioblastoma
por: Hong, Christopher S., et al.
Publicado: (2020)